Cargando…
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
[Image: see text]
Autores principales: | Oh, Sang‐Min, Chang, Mi‐Yoon, Song, Jae‐Jin, Rhee, Yong‐Hee, Joe, Eun‐Hye, Lee, Hyun‐Seob, Yi, Sang‐Hoon, Lee, Sang‐Hun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734846/ https://www.ncbi.nlm.nih.gov/pubmed/26882244 http://dx.doi.org/10.15252/emmm.201506162 |
Ejemplares similares
-
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
por: Oh, Sang-Min, et al.
Publicado: (2015) -
In vitro generation of mature midbrain-type dopamine neurons by adjusting exogenous Nurr1 and Foxa2 expressions to their physiologic patterns
por: Kim, Taeho, et al.
Publicado: (2017) -
Generation of Dopamine Neurons with Improved Cell Survival and Phenotype Maintenance Using a Degradation-Resistant Nurr1 Mutant
por: Jo, A-Young, et al.
Publicado: (2009) -
2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019) -
Corrigendum: Correction of Acknowledgments. Association between Serum Fibroblast Growth Factor 21 Levels and Bone Mineral Density in Postmenopausal Women
por: Choi, Hoon Sung, et al.
Publicado: (2018)